TC Medical(SH:600763) Sou Hu Cai Jing·2025-12-26 12:04Core Viewpoint - Tongce Medical (600763) shows a slight increase in stock price and mixed capital flow, indicating potential investor interest despite some outflows from major and retail investors [1][2]. Group 1: Stock Performance - As of December 26, 2025, Tongce Medical closed at 40.93 yuan, up 0.17% with a turnover rate of 0.87% and a trading volume of 38,700 lots, amounting to a transaction value of 159 million yuan [1]. - Over the past five days, the stock has experienced fluctuations in capital flow, with a net outflow of 21.4 million yuan from major investors on December 26, representing 13.49% of the total transaction value [2]. Group 2: Financial Metrics - Tongce Medical's total market capitalization is 18.308 billion yuan, with a net asset value of 4.703 billion yuan and a net profit of 514 million yuan [3]. - The company reported a year-on-year revenue increase of 2.56% for the first three quarters of 2025, with a total revenue of 2.29 billion yuan and a net profit of 514 million yuan [3]. - The company's gross margin stands at 41.69%, significantly higher than the industry average of 36.47%, and its net profit margin is 26.91%, compared to the industry average of 4.61% [3]. Group 3: Analyst Ratings - In the last 90 days, seven institutions have rated Tongce Medical, with four buy ratings and three hold ratings, indicating a generally positive outlook [4]. - The average target price set by analysts over the past 90 days is 52.88 yuan, suggesting potential upside from the current trading price [4].